Home

Mark Trudeau

CIK 1540412 · President and CEO · last filed 2025-11-14

Mark Trudeau is a President and CEO who has filed 59 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing, for TEL, was dated Nov 14, 2025. Across all open-market trades the lifetime net is −$7.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.49M

Companies

3

Total Filings

59

Lifetime Open-Market Net

-$7.00M

Filer Profile

Reported Address
COVIDIEN PLC
15 HAMPSHIRE STREET
MANSFIELD, MA 02048
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TEL Director 7,123 $208.65 $1.49M -$996.7K 12 2025-11-14
Keenova Therapeutics plc (MNK) Delisted President and CEO 11,312 $0.34 $3.8K -$6.01M 38 2022-06-21
Covidien plc (COV) Delisted Senior Vice President 29,262 — — $0 8 2013-05-07

Recent Filings

59 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-11-14 TEL Mixed +435 -$95.2K EDGAR
2024-11-15 TEL Mixed +771 -$85.2K EDGAR
2024-04-29 TEL Notice (144) −7,044 -$987.6K EDGAR
2024-04-29 TEL Sell (S) −7,044 -$996.7K EDGAR
2023-12-14 TEL Mixed +1,143 -$51.8K EDGAR
2022-11-16 TEL Mixed +1,281 -$53.3K EDGAR
2022-06-21 Keenova Therapeutics plc (MNK) Delisted Disp (D) — $0 EDGAR
2021-12-13 TEL Mixed +935 -$49.0K EDGAR
2020-11-16 Keenova Therapeutics plc (MNK) Delisted Sell (S) −217,072 -$27.4K EDGAR
2020-11-12 TEL Mixed +1,338 -$47.3K EDGAR
Showing 1–10 of 59
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.